Click on a filter below to refine your search. Remove a filter to broaden your search.
The agency has identified 226 reports so far that may meet its ‘working case definition’ of myocarditis and pericarditis.
Strategies that improve cardiovascular health also may improve outcomes for people following COVID-19.
The guidelines address myocarditis and other types of myocardial involvement, postacute sequelae of SARS-CoV-2 and return to exercise.
A subgroup analysis suggests that poor oral health may increase the severity of COVID-19 in patients with cardiovascular diseases.
But the myocarditis risk was higher after vaccination for men younger than age 40 years, particularly after the second dose of mRNA-1273.
The clinical lexicon presents data elements related to cardiovascular and noncardiovascular complications of COVID-19.
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
The findings were seen regardless of vaccination status and history of prior infection.
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.